We read with interest the Comment by Susan C Pitt and Megan Haymart1 on our Article on genetic modification of the American Joint Committee on Cancer (AJCC) staging system in papillary thyroid cancer2 and hold the following conservative opinions.
[Correspondence] Tumour genetics and thyroid cancer staging
The Lancet Oncology | | Mingzhao Xing
Topics: thyroid-cancer